Extended Data Fig. 6: Relative abundance of bacterial species biomarkers in controls and patients at inactive and active status.
From: Noninvasive, microbiome-based diagnosis of inflammatory bowel disease
a, The relative abundance of ten UC bacterial species biomarkers in controls and UC patients at inactive and active status. b, The relative abundance of nine CD bacterial species biomarkers in controls and CD patients at inactive and active status. e, Comparison of the probability of disease calculated by the random forest model between CD patients at inactive (N = 69) and active (N = 9) status. c, Comparison of the probability of disease calculated by the random forest model between UC patients at inactive (N = 110) and active (N = 11) status. d, Model performance in distinguishing inactive UC patients (N = 40) and controls (N = 42). f, Model performance in distinguishing inactive CD patients (N = 69) and controls (N = 108). Shaded areas of the ROC curves represent the 95% confidence interval of the AUC for each cohort. Data were shown in boxplots as the median (centre line), 25th and 75th percentiles (box limits), and 5th and 95th percentiles (whiskers). The gray diamond represents the mean value. P values were given by the two-sided Wilcoxon rank sum test. CD: Crohn’s disease; UC: Ulcerative colitis; IBS, Irritable bowel syndrome.
